Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.52B | 57.52B | 56.04B | 55.05B | 49.85B | 42.48B |
Gross Profit | 11.14B | 11.14B | 9.73B | 9.94B | 9.77B | 7.54B |
EBITDA | 5.35B | 5.35B | 4.09B | 4.03B | 5.46B | 4.15B |
Net Income | 1.19B | 1.19B | 342.00M | -257.00M | 2.35B | 1.05B |
Balance Sheet | ||||||
Total Assets | 77.80B | 77.80B | 79.12B | 73.03B | 71.49B | 67.91B |
Cash, Cash Equivalents and Short-Term Investments | 8.71B | 8.71B | 8.28B | 8.29B | 11.52B | 12.75B |
Total Debt | 24.59B | 24.59B | 25.58B | 24.88B | 25.06B | 25.64B |
Total Liabilities | 41.01B | 41.01B | 42.44B | 40.75B | 40.24B | 38.81B |
Stockholders Equity | 30.72B | 30.72B | 31.16B | 26.89B | 26.42B | 22.99B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 954.00M | -1.47B | -1.83B | 811.00M | 1.09B |
Operating Cash Flow | 0.00 | 4.64B | 2.78B | 2.23B | 4.06B | 3.57B |
Investing Cash Flow | 0.00 | -2.81B | -2.84B | -4.48B | -3.34B | -2.47B |
Financing Cash Flow | 0.00 | -1.70B | -241.00M | -1.38B | -2.12B | 3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥14.86B | 15.55 | 1.84% | 2.44% | 163.48% | ||
76 Outperform | ¥16.75B | 17.59 | 1.94% | 33.05% | ― | ||
72 Outperform | ¥16.86B | 18.33 | 1.47% | 29.02% | ― | ||
71 Outperform | ¥15.48B | 5.29 | 2.98% | -6.23% | 405.48% | ||
68 Neutral | ¥18.32B | 10.45 | 1.95% | 27.72% | 70.12% | ||
65 Neutral | $2.67B | 14.63 | 12.46% | 3.50% | 2.94% | 43.39% | |
54 Neutral | ¥13.64B | ― | 5.26% | -1.14% | 68.17% |